De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation.

被引：0
|
作者：
Petrossian, G. [1 ]
Ortiz, J. [2 ]
Addonizio, K. [1 ]
Hsiao, A. [1 ]
Teixeira, L. [1 ]
Koizumi, N. [3 ]
James, R. [3 ]
Patel, S. [4 ]
Conti, D. [2 ]
Plews, R. [2 ]
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Albany Med Ctr, Div Renal & Pancreat Transplant Serv, Albany, NY USA
[3] George Mason Univ, Fairfax, VA 22030 USA
[4] UMC Las Vegas, Las Vegas, NV USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
413
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [11] De novo minimal change disease (mcd) following kidney transplantation.
    Ghuman, Nimrta
    Patel, Vedavati
    de Palma, John
    Datla, Arvind
    Nataraj, Swetha
    Ranga, K. Vinay
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 51 (04) : A49 - A49
  • [12] Development of De-novo Malignancies After Kidney and/or Pancreas Transplantation in Diabetic Patients
    Gruessner, A.
    Saggi, S.
    Renz, J.
    Gruessner, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 831 - 831
  • [13] URS for de-novo urolithiasis after kidney transplantation: a systematic review of the literature
    Cerrato, Clara
    Nedbal, Carlotta
    Jahrreiss, Victoria
    Ripa, Francesco
    DE Marco, Vincenzo
    Monga, Manoj
    Hameed, Belthangady M.
    Kronenberg, Peter
    Pietropaolo, Amelia
    Naik, Nitesh
    Somani, Bhaskar
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (03): : 286 - 294
  • [14] Prospective Monitoring of CMV, EBV, BKV, and JCV Infections on Belatacept Therapy after Kidney Transplantation
    Kamar, N.
    Bassil, N.
    Esposito, L.
    Mengelle, C.
    Guitard, J.
    Cardeau-Desangles, I.
    Izopet, J.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 70 - 70
  • [15] Increased incidence and unusual presentations of CMV disease in kidney transplant recipients after conversion to belatacept
    Chavarot, Nathalie
    Divard, Gillian
    Scemla, Anne
    Amrouche, Lucile
    Aubert, Olivier
    Leruez-Ville, Marianne
    Timsit, Marc O.
    Tinel, Claire
    Zuber, Julien
    Legendre, Christophe
    Anglicheau, Dany
    Sberro-Soussan, Rebecca
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (07) : 2448 - 2458
  • [16] A Randomized Controlled Clinical Trial Comparing Belatacept With Tacrolimus After De Novo Kidney Transplantation
    de Graav, Gretchen N.
    Baan, Carla C.
    Clahsen-van Groningen, Marian C.
    Kraaijeveld, Rens
    Dieterich, Marjolein
    Verschoor, Wenda
    von der Thusen, Jan H.
    Roelen, Dave L.
    Cadogan, Monique
    van de Wetering, Jacqueline
    van Rosmalen, Joost
    Weimar, Wilem
    Hesselink, Dennis A.
    TRANSPLANTATION, 2017, 101 (10) : 2571 - 2581
  • [17] Lack of association between cytomegalovirus (CMV) risk and cardiovascular disease (CVD) mortality after kidney transplantation.
    Kasiske, BL
    Snyder, JJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 191A - 191A
  • [18] Incidence and Predictors of De Novo Renal Cell Carcinoma after Kidney Transplantation.
    Graham, Lindsey J.
    Hurst, Frank P.
    Jindal, Rahul M.
    Falta, Edward M.
    Agodoa, Lawrence Y.
    Neff, Robert T.
    Abbott, Kevin C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 238 - 238
  • [19] De-novo malignancies after kidney transplantation: A long-term observational study
    Froehlich, Felix A.
    Halleck, Fabian
    Lehner, Lukas
    Schrezenmeier, Eva V.
    Naik, Marcel
    Schmidt, Danilo
    Khadzhynov, Dmytro
    Kast, Katharina
    Budde, Klemens
    Staeck, Oliver
    PLOS ONE, 2020, 15 (11):
  • [20] Comment on: "URS for de-novo urolithiasis after kidney transplantation: a systematic review of the literature"
    Piana, Alberto
    Pecoraro, Alessio
    Lopez-Abad, Alicia
    Prudhomme, Thomas
    Marco, Beatriz Banuelos
    Haberal, Hakan Bahadir
    Donmez, M. Irfan
    Campi, Riccardo
    Territo, Angelo
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (05): : 667 - 669
12345